References
- Parler CW. Allergic mediators. In: Korenblat PE, Wedner HJ, editors. Allergy: Theory and Practice. Philadelphia: Saunders, 1992; 87–89.
- Salmon JA, Higgs GA. The eicosanoids: generation and actions. In: Dale MM, Foreman JC, Fan TP, editors. Textbook of Immunophar-macology, 3rd ed. Oxford, Boston: Blackwell Science, 1993; 131–143.
- Mukherjee AB, Miele L, Pattabiraman N. Phospholipase A, enzymes: regulation and physiological role. Biochem Pharmacol 1994;48:1–10.
- Henderson WR Jr. Eicosanoids and platelet-activating factor in allergic respiratory diseases. Am Rev Respir Dis 1991;143:586–590.
- Touqui L, Herpin-Richard N, Gene R-M, et al. Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. J Allergy Clin Inmmunol 1994;94;109–119.
- Claman HN, Tilles SA. Immunosup-pressive and antiinflammatory actions of corticosteroids. In: Austen ICF, Burakoff SJ, Rosen FS, Strom TB, editors. Therapeutic Immunology. Oxford, Boston: Blackwell Science, 1996; 1°5–118.
- Talar-Williams C, Sneller MC. Complications of corticosteroid therapy. Eur Arch Otorhinolaryngol 1994;251:131–136.
- Caterina RD, Sicari R, Giannessi D, et al. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-I induction by glucocorticoids. J Appl Physiol 1993;75:2368–2375.
- Miele L, Cordella-Miele E, Mukherjee AB. Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A, inhibitor. Endocrinol Rev 1987;8;474–490.
- Miele L, Cordella-Miele E, Facchiano A, Mukherjee AB. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 1988;335:726–730.
- Chan CC, Ni M, Miele L, et al. Effects of antiflammins on endotoxin-induced uveitis in rats. Arch Ophthalmol 1991;109:278–281.
- Paton WDM. Compound 48/80: a potent histamine liberator. Br J Pharmacol 1951;6:499–508.
- Li Q, Luyo D, Hikita N, Whitcup SM, Jong US, Chan C-C. Compound 48/80-induced conjunctivitis in the mouse: kinetics, susceptibility, and mechanism. Int Arch Allergy Immunol 1996;109: 277–285.
- Brenner T, Brocke S, Szafer F, Sobel RA, Parkinson JF, Perez DH, Steinman L. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol 1997;158:2940–2946.
- Hsu SM, Raine L, Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxi-dase technique: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 1981;92:577–580.
- Gazzinelli RT, Eltoum I, Wynn TA, Sher A. Acute cerebral toxoplasmo-sis is induced by in vivo neutralization of TNF-a and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 1993;151:3672–3681.
- Vickerstaff JM, Bielory L. Type I hypersensitivity: atopic allergy. In: Vickerstaff Joneja JM, Bielory L, editors. Understanding Allergy, Sensitivity, and Immunity, A Comprehensive Guide. New Brunswick: Rutgers University Press, 1990; 126–136.
- Lake AM, Bloch KJ, Sinclair KJ, Walker WA. Anaphylactic release of intestinal goblet cell mucus. Immunology 1980;39:173–178.
- Blackwell GJ, Flower RJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 1979;278:456–459.
- Hirata F, Schiffmann E, Venkatasubramanian K, Salomon D, Axelrod J. A phospholipase A2 inhibitory protein induced in rabbit neutrophils by glucocorticoids. Proc Natl Acad Sci USA 1980;77: 2533–2536.
- Nathan C, Xie QW. Regulation and biosynthesis of nitric oxide. J Biol Chem 1994;269:13725–13728.
- Dugas B, Debre P, Moncada S. Nitric oxide, a vital poison inside the immune and inflammatory network. Res Immunol 1995;146:664–670.
- Del Pozo V, De Arruda-Chaves E, De Andres B, et al. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol 1997;158:859–864.